Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Acid, Chenic
2. Acid, Chenique
3. Acid, Chenodeoxycholic
4. Acid, Gallodesoxycholic
5. Chenic Acid
6. Chenique Acid
7. Chenix
8. Chenodeoxycholate
9. Chenodeoxycholate, Sodium
10. Chenodiol
11. Chenofalk
12. Chenophalk
13. Gallodesoxycholic Acid
14. Henohol
15. Quenobilan
16. Quenocol
17. Sodium Chenodeoxycholate
1. Chenodiol
2. 474-25-9
3. Chenix
4. Chenic Acid
5. Cdca
6. Chenodeoxycholate
7. Chenodesoxycholic Acid
8. Gallodesoxycholic Acid
9. Chendol
10. Anthropodeoxycholic Acid
11. Anthropodesoxycholic Acid
12. Chenofalk
13. Anthropododesoxycholic Acid
14. Chenodesoxycholsaeure
15. Chenodiol [usan]
16. Chenocol
17. Chenossil
18. Cholanorm
19. Fluibil
20. Xenbilox
21. Chenocholic Acid
22. 3alpha,7alpha-dihydroxy-5beta-cholan-24-oic Acid
23. Acido Chenodeoxicholico
24. 3alpha,7alpha-dihydroxy-5beta-cholanic Acid
25. Chenodesoxycholsaeure [german]
26. Acide Chenodeoxycholique
27. 7-alpha-hydroxylithocholic Acid
28. Acidum Chenodeoxycholicum
29. 7alpha-hydroxylithocholic Acid
30. Acide Chenodeoxycholique [inn-french]
31. Acido Chenodeoxicholico [inn-spanish]
32. Acidum Chenodeoxycholicum [inn-latin]
33. 3-alpha,7-alpha-dihydroxycholanic Acid
34. 3-alpha,7-alpha-dihydroxycholansaeure [german]
35. (4r)-4-[(3r,5s,7r,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoic Acid
36. 3-alpha,7-alpha-dihydroxycholansaeure
37. 0gei24lg0j
38. Chenodeoxycholic Acid [inn]
39. 3-alpha,7-alpha-dihydroxy-5-beta-cholan-24-oic Acid
40. Chebi:16755
41. Cholan-24-oic Acid, 3,7-dihydroxy-, (3alpha,5beta,7alpha)-
42. Chenodiol (usan)
43. Cholan-24-oic Acid, 3,7-dihydroxy-, (3a,5b,7a)-
44. Nsc-657949
45. Nsc-757798
46. (3alpha,5beta,7alpha)-3,7-dihydroxycholan-24-oic Acid
47. 5-beta-cholan-24-oic Acid, 3-alpha,7-alpha-dihydroxy-
48. (3alpha,5beta,7alpha,8xi)-3,7-dihydroxycholan-24-oic Acid
49. Henohol
50. Chenique Acid
51. Cholan-24-oic Acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-alpha)-
52. Dsstox_cid_260
53. Dsstox_rid_75469
54. Dsstox_gsid_20260
55. 3.alpha.,7.alpha.-dihydroxy-5.beta.-cholan-24-oic Acid
56. (4r)-4-[(1s,2s,5r,7s,9r,10r,11s,14r,15r)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic Acid
57. Chendeoxycholic Acid
58. Ccris 2195
59. Einecs 207-481-8
60. Unii-0gei24lg0j
61. Nsc 657949
62. Chenocedon
63. Chendal
64. Chenodex
65. Chenorm
66. Hekbilin
67. Kebilis
68. Mfcd00064142
69. Nsc657949
70. Ncgc00016387-02
71. (r)-4-((3r,5s,7r,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic Acid
72. Cas-474-25-9
73. Jn3
74. Chenodeoxycholic-acid
75. (+)-chenodeoxycholate
76. Chenodiol [mi]
77. Prestwick0_000285
78. Prestwick1_000285
79. Prestwick2_000285
80. Prestwick3_000285
81. Spectrum5_002009
82. Chenix (tn)
83. Chenodiol [vandf]
84. (+)-chenodeoxycholic Acid
85. Bmse000908
86. 7a-hydroxy-desoxycholsaeure
87. Ec 207-481-8
88. Bidd:pxr0056
89. Schembl25055
90. Bspbio_000190
91. Gtpl608
92. Mls002154253
93. 3a,7a-dihydroxy-5b-cholanate
94. Spbio_002409
95. 3,7-dihydroxy-5-cholanicacid
96. Bpbio1_000210
97. Chembl240597
98. Chenodeoxycholic Acid, >=97%
99. Chenodiol [orange Book]
100. Dtxsid2020260
101. 7.alpha.-hydroxylithocholic Acid
102. Bdbm21674
103. Chenodeoxycholic Acid, Free Acid
104. 3a,7a-dihydroxy-5b-cholanic Acid
105. Hms1568j12
106. Hms2095j12
107. Hms2234i22
108. Hms3712j12
109. Chenodeoxycholic Acid (jp16/inn)
110. Chenodeoxycholic Acid (jp17/inn)
111. Chenodeoxycholic Acid [jan]
112. Zinc3914808
113. Tox21_110412
114. Tox21_200491
115. (3beta,7beta,8xi,9xi,14xi,17alpha)-3,7-dihydroxycholan-24-oic Acid
116. 3a,7a-dihydroxy-5b-cholan-24-oate
117. Cholan-24-oic Acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.alpha.)-
118. Hsci1_000210
119. Lmst04010032
120. Chenodeoxycholic Acid [mart.]
121. Akos024280614
122. Chenodeoxycholic Acid [who-dd]
123. Ccg-220285
124. Cs-0834
125. Db06777
126. 5beta-cholanic Acid-3alpha,7alpha-diol
127. Smp1_000064
128. 3.alpha.,7.alpha.-dihydroxycholansaeure
129. 3a,7a-dihydroxy-5b,14a,17b-cholanate
130. 3a,7a-dihydroxy-5b-cholan-24-oic Acid
131. Ncgc00142400-03
132. Ncgc00142400-04
133. Ncgc00142400-08
134. Ncgc00258045-01
135. (4r)-4-((1s,2s,7s,11s,5r,9r,10r,14r,15r)-5,9-dihydroxy-2,15-dimethyltetracyclo [8.7.0.0<2,7>.0<11,15>]heptadec-14-yl)pentanoic Acid
136. 24404-86-2
137. 3.alpha.,7.alpha.-dihydroxycholanic Acid
138. As-13636
139. Hy-76847
140. Smr000857194
141. Chenodeoxycholic Acid [ep Impurity]
142. Chenodeoxycholic Acid [ep Monograph]
143. 3a,7a-dihydroxy-5b,14a,17b-cholanic Acid
144. Ab00513822
145. S1843
146. (3a,5b,7a)-3,7-dihydroxy-cholan-24-oate
147. 3alpha, 7alpha-dihydroxy-5beta-cholanoic Acid
148. 3alpha, 7alpha,-dihydroxy-5beta-cholanic Acid
149. C-2900
150. C02528
151. D00163
152. (3a,5b,7a)-3,7-dihydroxy-cholan-24-oic Acid
153. Ab00513822-06
154. Ab00513822_07
155. A827222
156. Q419028
157. 3.alpha.,7.alpha.-dihydroxy-5.beta.-cholanic Acid
158. Dihydroxy-3.alpha.,7.alpha.(5.beta.)cholanic Acid
159. Leadiant (formerly Chenodeoxycholic Acid Sigma-tau)
160. (3
161. A,5
162. A,7
163. A)-3,7-dihydroxycholan-24-oic Acid
164. 3.alpha.,7.alpha.-dihydroxy-5.beta.-cholanoic Acid
165. Brd-k18135438-001-16-7
166. Ursodeoxycholic Acid Impurity A [ep Impurity]
167. 0dbbbc66-0cfa-4db9-97f4-5b1492756a02
168. Z1270387252
169. 5.beta.-cholan-24-oic Acid, 3.alpha.,7.alpha.-dihydroxy-
170. (3alpha,5alpha,7beta,8alpha,17alpha)-3,7-dihydroxycholan-24-oic Acid
171. 3,7-dihydroxycholan-24-oic Acid, (3.alpha.,5.beta.,7.alpha.)- #
172. Chenodeoxycholic Acid, 500 Mug/ml In Methanol, Certified Reference Material
173. Chenodeoxycholic Acid, European Pharmacopoeia (ep) Reference Standard
174. Cholan-24-oic Acid, 3,7-dihydroxy-, (3-.alpha., 5-.beta., 7-.alpha.)-
175. Cholan-24-oic Acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-alpha)- (9ci)
176. Cholan-24-oic Acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.alpha.)
177. (4r)-4-[(1s,2s,5r,7s,9r,10r,11s,14r,15r)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0?,?.0??,??]heptadecan-14-yl]pentanoic Acid
Molecular Weight | 392.6 g/mol |
---|---|
Molecular Formula | C24H40O4 |
XLogP3 | 4.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 392.29265975 g/mol |
Monoisotopic Mass | 392.29265975 g/mol |
Topological Polar Surface Area | 77.8 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 605 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Chenodiol |
PubMed Health | Chenodiol (By mouth) |
Drug Classes | Gastrointestinal Agent |
Drug Label | Chenodiol is the non-proprietary name for chenodeoxycholic acid, a naturally occurring human bile acid. It is a bitter-tasting white powder consisting of crystalline and amorphous particles freely soluble in methanol, acetone and acetic acid and prac... |
Active Ingredient | Chenodiol |
Dosage Form | Tablet |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Nexgen Pharma |
2 of 2 | |
---|---|
Drug Name | Chenodiol |
PubMed Health | Chenodiol (By mouth) |
Drug Classes | Gastrointestinal Agent |
Drug Label | Chenodiol is the non-proprietary name for chenodeoxycholic acid, a naturally occurring human bile acid. It is a bitter-tasting white powder consisting of crystalline and amorphous particles freely soluble in methanol, acetone and acetic acid and prac... |
Active Ingredient | Chenodiol |
Dosage Form | Tablet |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Nexgen Pharma |
Chenodiol is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age. Chenodiol will not dissolve calcified (radiopaque) or radiolucent bile pigment stones.
FDA Label
Chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in infants, children and adolescents aged 1 month to 18 years and adults.
It acts by reducing levels of cholesterol in the bile, helping gallstones that are made predominantly of cholesterol to dissolve. Chenodeoxycholic acid is ineffective with stones of a high calcium or bile acid content.
Cathartics
Agents that are used to stimulate evacuation of the bowels. (See all compounds classified as Cathartics.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
A05AA01
A - Alimentary tract and metabolism
A05 - Bile and liver therapy
A05A - Bile therapy
A05AA - Bile acids and derivatives
A05AA01 - Chenodeoxycholic acid
Absorption
Chenodiol is well absorbed from the small intestine.
Route of Elimination
About 80% of its bacterial metabolite lithocholate is excreted in the feces.
Chenodiol is well absorbed from the small intestine and taken up by the liver where it is converted to its taurine and glycine conjugates and secreted in bile. At steady-state, an amount of chenodiol near the daily dose escapes to the colon and is converted by bacterial action to lithocholic acid. About 80% of the lithocholate is excreted in the feces; the remainder is absorbed and converted in the liver to its poorly absorbed sulfolithocholyl conjugates. During chenodiol therapy there is only a minor increase in biliary lithocholate, while fecal bile acids are increased three- to fourfold.
Chenodiol suppresses hepatic synthesis of both cholesterol and cholic acid, gradually replacing the latter and its metabolite, deoxycholic acid in an expanded bile acid pool. These actions contribute to biliary cholesterol desaturation and gradual dissolution of radiolucent cholesterol gallstones in the presence of a gall-bladder visualized by oral cholecystography. Bile acids may also bind the the bile acid receptor (FXR) which regulates the synthesis and transport of bile acids.
ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31188
Submission : 2016-11-21
Status : Active
Type : II
Certificate Number : R1-CEP 2003-238 - Rev 01
Issue Date : 2020-06-05
Type : TSE
Substance Number : 1189
Status : Valid
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2021-03-18
Registration Number : 20210318-211-J-892
Manufacturer Name : ICE SpA@ ICE SPA@Raichem Medicare Pvt. Ltd
Manufacturer Address : Via Sicilia, 8-10 42122 Reggio Emilia ITALY @Via Novi 78, 15060 Basaluzzo(AL), Italy@Plot No. 24, 25 & 26, Raichur Industrial Growth Centre, Chicksugur - 584 134, Dist : Raichur, Karnataka, India_x000D_
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2001
Submission : 1972-09-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4585
Submission : 1982-05-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2157
Submission : 1973-10-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2356
Submission : 1974-11-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2268
Submission : 1974-04-30
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2930
Submission : 1977-04-25
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4958
Submission : 1983-02-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12676
Submission : 1997-10-01
Status : Inactive
Type : II
ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31188
Submission : 2016-11-21
Status : Active
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2001
Submission : 1972-09-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4585
Submission : 1982-05-25
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3236
Submission : 1978-06-14
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3067
Submission : 1977-11-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2606
Submission : 1976-02-05
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2930
Submission : 1977-04-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2268
Submission : 1974-04-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2356
Submission : 1974-11-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2157
Submission : 1973-10-01
Status : Inactive
Type : II
ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
Chenodeoxycholic acid and ursodeoxycholic acid magnesium trihydrate
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2021-03-18
Registration Number : 20210318-211-J-892
Manufacturer Name : ICE SpA@ ICE SPA@Raichem Med...
Manufacturer Address : Via Sicilia, 8-10 42122 Reggio Emilia ITALY @Via Novi 78, 15060 Basaluzzo(AL), Italy@...
Chenodeoxycholic acid and ursodeoxycholic acid magnesium trihydrate
Registrant Name : Daewoong Bio Co., Ltd.
Registration Date : 2022-03-17
Registration Number : 20220317-211-J-1252
Manufacturer Name : Daewoong Bio Co., Ltd.
Manufacturer Address : 29, Yakjedanji-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
03 Mar 2022
Reply
10 Aug 2021
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Chenodeoxycholic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chenodeoxycholic Acid, including repackagers and relabelers. The FDA regulates Chenodeoxycholic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chenodeoxycholic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chenodeoxycholic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chenodeoxycholic Acid supplier is an individual or a company that provides Chenodeoxycholic Acid active pharmaceutical ingredient (API) or Chenodeoxycholic Acid finished formulations upon request. The Chenodeoxycholic Acid suppliers may include Chenodeoxycholic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Chenodeoxycholic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chenodeoxycholic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of Chenodeoxycholic Acid active pharmaceutical ingredient (API) in detail. Different forms of Chenodeoxycholic Acid DMFs exist exist since differing nations have different regulations, such as Chenodeoxycholic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chenodeoxycholic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. Chenodeoxycholic Acid USDMF includes data on Chenodeoxycholic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chenodeoxycholic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chenodeoxycholic Acid suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Chenodeoxycholic Acid Drug Master File in Korea (Chenodeoxycholic Acid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Chenodeoxycholic Acid. The MFDS reviews the Chenodeoxycholic Acid KDMF as part of the drug registration process and uses the information provided in the Chenodeoxycholic Acid KDMF to evaluate the safety and efficacy of the drug.
After submitting a Chenodeoxycholic Acid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Chenodeoxycholic Acid API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Chenodeoxycholic Acid suppliers with KDMF on PharmaCompass.
A Chenodeoxycholic Acid CEP of the European Pharmacopoeia monograph is often referred to as a Chenodeoxycholic Acid Certificate of Suitability (COS). The purpose of a Chenodeoxycholic Acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Chenodeoxycholic Acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Chenodeoxycholic Acid to their clients by showing that a Chenodeoxycholic Acid CEP has been issued for it. The manufacturer submits a Chenodeoxycholic Acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a Chenodeoxycholic Acid CEP holder for the record. Additionally, the data presented in the Chenodeoxycholic Acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Chenodeoxycholic Acid DMF.
A Chenodeoxycholic Acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Chenodeoxycholic Acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Chenodeoxycholic Acid suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chenodeoxycholic Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chenodeoxycholic Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chenodeoxycholic Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chenodeoxycholic Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chenodeoxycholic Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chenodeoxycholic Acid suppliers with NDC on PharmaCompass.
Chenodeoxycholic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chenodeoxycholic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chenodeoxycholic Acid GMP manufacturer or Chenodeoxycholic Acid GMP API supplier for your needs.
A Chenodeoxycholic Acid CoA (Certificate of Analysis) is a formal document that attests to Chenodeoxycholic Acid's compliance with Chenodeoxycholic Acid specifications and serves as a tool for batch-level quality control.
Chenodeoxycholic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Chenodeoxycholic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chenodeoxycholic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Chenodeoxycholic Acid EP), Chenodeoxycholic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chenodeoxycholic Acid USP).
LOOKING FOR A SUPPLIER?